Devyser Diagnostics ABFRA:OL0 -2.60%79 Gross Margin % is 81.72% as of Mar. 2026, which is 4% above its 10-year median of 78.28. GuruFocus rates FRA:OL0 with a GF Score™ of 79/100 and a GF Value™ of €13.58 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Devyser Diagnostics AB ranks better than 91.81% on this metric.
FRA:OL0's Gross Margin % is ranked better than 91.81% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 51.985
vs FRA:OL0: 80.28
Devyser Diagnostics AB had a gross margin of 81.72% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Devyser Diagnostics AB was 2.10% per year.
Devyser Diagnostics AB (FRA:OL0) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Devyser Diagnostics AB had a gross margin of 81.72% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Devyser Diagnostics AB Gross Margin % Related Terms
Devyser Diagnostics AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Devyser Diagnostics AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:OL0 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Devyser Diagnostics AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Devyser Diagnostics AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Devyser Diagnostics AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Devyser Diagnostics AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Devyser Diagnostics AB (FRA:OL0) has a Gross Margin % of 81.72% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Devyser Diagnostics AB and its competitors. This is near median its historical median of 78.28. Over the past decade, Devyser Diagnostics AB's Gross Margin % has ranged from 67.96 to 85.47. According to the industry distribution chart, Devyser Diagnostics AB ranks #66 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 8.2%.
Is Devyser Diagnostics AB's Gross Margin % too high?
Devyser Diagnostics AB's current Gross Margin % of 81.72% is near median its 10-year median of 78.28. Over the past 10 years, this metric has ranged from a low of 67.96 to a high of 85.47. The Medical Devices & Instruments industry median Gross Margin % is 51.99. Devyser Diagnostics AB's value of 81.72% is 57.2% above this industry median. Based on the distribution chart, Devyser Diagnostics AB ranks #66 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Devyser Diagnostics AB has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Devyser Diagnostics AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Devyser Diagnostics AB ranks #66 out of 806 companies for Gross Margin %. This places Devyser Diagnostics AB in the top 8% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 51.99. Devyser Diagnostics AB's value of 81.72% is 57.2% above this benchmark. Historically, Devyser Diagnostics AB's own Gross Margin % has ranged from 67.96 to 85.47 over the past decade. While the company's 10-year median is 78.28 vs. the industry median of 51.99, Devyser Diagnostics AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.99, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Devyser Diagnostics AB's current Gross Margin % of 81.72% is 57.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Devyser Diagnostics AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Devyser Diagnostics AB's current Gross Margin % is 81.72%, which is near median its own 10-year median of 78.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devyser Diagnostics AB stock overvalued right now?
Based on GuruFocus' analysis, Devyser Diagnostics AB (FRA:OL0) is currently considered Significantly Undervalued. The stock's GF Value™ is €13.58, compared to a current price of €7.49 — trading 44.8% below its estimated fair value. The current Gross Margin % is 81.72%, which is near median its 10-year median of 78.28 and 57.2% above the Medical Devices & Instruments industry median of 51.99. Devyser Diagnostics AB's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Devyser Diagnostics AB (FRA:OL0), the current Gross Margin % is 81.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Devyser Diagnostics AB (FRA:OL0) Overvalued in 2026?
Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued.
The current stock price of €7.49 is trading 44.8% below its estimated GF Value™ of €13.58.
GuruFocus considers Devyser Diagnostics AB to be Significantly Undervalued.
Key valuation signals for FRA:OL0:
Gross Margin %: 81.72% (near median its 10-year median of 78.28)
GF Value™: €13.58 vs. price of €7.49 (44.8% below fair value)
Industry Position: 57.2% above the Medical Devices & Instruments median (#66 of 806)
No single metric tells the full story. See the FRA:OL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
79GF Score
Get the complete analysis for FRA:OL0
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OL0 has been successfully added to your 
